WallachBeth Capital Facilitates $1.4 Million Warrant Transaction
WallachBeth Capital LLC, known for its expertise in capital markets and institutional execution services, has announced an exciting development. bioAffinity Technologies, Inc. (NASDAQ: BIAF) has successfully concluded its recent warrant exercise agreements. This transaction involved four accredited investors who took the opportunity to exercise their outstanding warrants, amounting to an impressive total of 2,438,473 shares of the company's common stock.
Details of the Warrant Exercise Agreements
In exchange for the immediate exercise of these Existing Warrants, the investors provided approximately $1.4 million in gross cash proceeds. As a result, these investors will gain new unregistered warrants, known as New Warrants, which offer the right to purchase up to 2,926,166 shares of common stock. This number represents 120% of the shares corresponding to the Existing Warrants exercised. The exercise price for the New Warrants is set at $0.85 per share.
Conditions and Duration of New Warrants
The New Warrants will become effective once stockholder approval is received, allowing for their exercise. Additionally, these warrants will have a five-year validity period starting from the date the approval is granted. In a generous move to incentivize participation, the company has also slashed the exercise price for the Existing Warrants significantly from $1.50 down to $0.58 per share.
Projected Financial Outcomes
The overall gross proceeds from this warrant inducement transaction are estimated to be around $1.4 million. It's essential to note that this figure excludes any potential earnings from the exercise of the New Warrants and is before accounting for placement agent fees and other related expenses incurred by the company.
Role of WallachBeth Capital in the Transaction
WallachBeth Capital played a crucial role as the sole placement agent for this warrant inducement transaction, showcasing its dedication to delivering valuable services tailored to the needs of companies like bioAffinity Technologies.
About WallachBeth Capital LLC
WallachBeth Capital stands out for its comprehensive array of capital markets and investment banking services tailored specifically for the healthcare industry. By connecting corporate clients with major institutions, they support both issuers and investors in reaching their financial aspirations. The firm's rich experience encompasses a spectrum of services, including initial public offerings, follow-on issues, PIPE offerings, private transactions, and at-the-market transactions.
Frequently Asked Questions
What is the total amount raised through the warrant exercise?
The total amount raised through the warrant exercise agreements is approximately $1.4 million.
How many new warrants were issued as part of the transaction?
A total of 2,926,166 New Warrants were issued, equaling 120% of the shares from the Existing Warrants.
What was the exercise price for the New Warrants?
The exercise price for the New Warrants is set at $0.85 per share.
How long are the New Warrants valid?
The New Warrants will be valid for five years from the date shareholder approval is obtained.
What company facilitated this transaction?
WallachBeth Capital LLC facilitated this warrant inducement transaction for bioAffinity Technologies, Inc.
